What is The Spectranetics Return-on-Tangible-Equity?
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. The Spectranetics's annualized net income for the quarter that ended in Jun. 2017 was $-98.4 Mil. The Spectranetics's average shareholder tangible equity for the quarter that ended in Jun. 2017 was $-192.4 Mil. Therefore, The Spectranetics's annualized Return-on-Tangible-Equity for the quarter that ended in Jun. 2017 was N/A%.
The historical rank and industry rank for The Spectranetics's Return-on-Tangible-Equity or its related term are showing as below:
SPNC's Return-on-Tangible-Equity is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.87 * Ranked among companies with meaningful Return-on-Tangible-Equity only.
The Spectranetics Return-on-Tangible-Equity Historical Data
The historical data trend for The Spectranetics's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of The Spectranetics's Return-on-Tangible-Equity
For the Medical Devices subindustry, The Spectranetics's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Spectranetics's Return-on-Tangible-Equity Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, The Spectranetics's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where The Spectranetics's Return-on-Tangible-Equity falls into.
The Spectranetics Return-on-Tangible-Equity Calculation
The Spectranetics's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2016 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Jun. 2017) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
The Spectranetics (NAS:SPNC) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
The Spectranetics Return-on-Tangible-Equity Related Terms
Thank you for viewing the detailed overview of The Spectranetics's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.
The Spectranetics (The Spectranetics) Business Description
Spectranetics manufactures and sells single-use medical devices used in minimally invasive cardiovascular procedures. The firm operates in the three categories: vascular intervention, lead management, and laser, service, and other. The vascular intervention business contributes the majority of revenue and sells laser and aspiration catheters, balloon catheters, and support catheters. The lead management business sells devices used to remove pacemaker and defibrillator cardiac leads. The laser, service, and other business includes a laser system for cardiovascular procedures. Spectranetics generates the vast majority of its revenue in the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SPNC has been successfully added to your 